| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 321 | 21 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -321 | -21 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -321 | -21 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Orin Medical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 495 | 488 | 479 | 470 | 461 | 452 | 442 | 443 | 442 | 440 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 429 | 425 | 418 | 410 | 402 | 394 | 386 | 387 | 386 | 384 |
| Cash | 66 | 63 | 61 | 60 | 59 | 58 | 56 | 57 | 56 | 56 |
| Shareholders Funds | -5.243 | -5.210 | -5.125 | -5.031 | -4.933 | -4.840 | -4.733 | -4.747 | -4.733 | -4.706 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.759 | 5.700 | 5.604 | 5.501 | 5.394 | 5.292 | 5.175 | 5.191 | 5.175 | 5.146 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Orin Medical Research Srl